(Q44998040)

8 December 2017

title

Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala (English)

1 reference

8 December 2017

0 references

1 reference

2

Benjamin F Cravatt

1 reference

8 December 2017

Sachin Patel

1

1 reference

8 December 2017

Cecilia J Hillard

series ordinal

3

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

8 December 2017

published in

Neuropsychopharmacology

1 reference

8 December 2017

volume

30

1 reference

8 December 2017

issue

3

1 reference

8 December 2017

page(s)

497-507

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300535

8 December 2017

exact match

0 references

cites work

Changes in anxiety feelings following marihuana smoking. The alternation in feelings of anxiety resulting from the smoking of marihuana (Cannabis sativa L.).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Asymmetry in behavioral responses to cholecystokinin microinjected into rat nucleus accumbens and amygdala.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Dopamine gates LTP induction in lateral amygdala by suppressing feedforward inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

The cannabinoid agonist HU 210 modifies rat behavioural responses to novelty and stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Modulation of anxiety through blockade of anandamide hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Environmental stress as a factor in the response of rat brain catecholamine metabolism to delta8-tetrahydrocannabinol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

The endogenous cannabinoid system controls extinction of aversive memories

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Localization of cannabinoid receptor mRNA in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Interactions of marijuana and induced stress: forearm blood flow, heart rate, and skin conductance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Neurobehavioral effects of delta 9-THC and cannabinoid (CB1) receptor gene expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Cannabinoid-induced Fos expression within A10 dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Long-term cannabis use: characteristics of users in an Australian rural area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

The amygdaloid complex: anatomy and physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

A community survey of adverse effects of cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

7 January 2021

Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

7 January 2021

Internalization and Recycling of the CB1 Cannabinoid Receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

7 January 2021

Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

7 January 2021

Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

7 January 2021

Delta 9 -tetrahydrocannabinol and ethanol: differential effects on sympathetic activity in differing environmental setting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

7 January 2021

Contextual Inhibitory Gating of Impulse Traffic in the Intra‐amygdaloid Network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

7 January 2021

Inhibition of the Amygdala: Key to Pathological States?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

7 January 2021

Stimulation of Medial Prefrontal Cortex Decreases the Responsiveness of Central Amygdala Output Neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

7 January 2021

An inhibitory interface gates impulse traffic between the input and output stations of the amygdala

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

7 January 2021

Polarized synaptic interactions between intercalated neurons of the amygdala

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300535

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300535

1 reference

8 December 2017

1 reference